GS-CA compounds: first-in-class HIV-1 capsid inhibitors covering multiple grounds

June 20, 2019

Singh K., Gallazzi F., Hill K.J., et al.

Frontiers in Microbiology 2019, vol: 10 doi: 10.3389/fmicb.2019.01227

Abstract

Recently reported HIV-1 capsid (CA) inhibitors GS-CA1 and GS-6207 (an analog of GS-CA1) are first-in-class compounds with long-acting potential. Reportedly, both compounds have greater potency than currently approved anti-HIV drugs. Due to the limited access to experimental data and the compounds themselves, a detailed mechanism of their inhibition is yet to be delineated. Using crystal structures of capsid-hexamers bound to well-studied capsid inhibitor PF74 and molecular modeling, we predict that GS-CA compounds bind in the pocket that is shared by previously reported CA inhibitors and host factors. Additionally, comparative modeling suggests that GS-CA compounds have unique structural features contributing to interactions with capsid. To test their proposed binding mode, we also report the design of a cyclic peptide combining structural units from GS-CA compounds, host factors, and previously reported capsid inhibitors. This peptide (Pep-1) binds CA-hexamer with a docking score comparable to GS-CA compounds. Affinity determination by MicroScale thermophoresis (MST) assays showed that CA binds Pep-1 with a ~7-fold better affinity than well-studied capsid inhibitor PF74, suggesting that it can be developed as a possible CA inhibitor.

View Publication
 

Topics: Virology, Monolith – MicroScale Thermophoresis, MST,  Publications

 

 

 

Previous Article
The amyloidogenicity of the influenza virus PB1-derived peptide sheds light on its antiviral activity
The amyloidogenicity of the influenza virus PB1-derived peptide sheds light on its antiviral activity

Up next
Cucumber mosaic virus coat protein: the potential target of 1, 4-pentadien-3-one derivatives
Cucumber mosaic virus coat protein: the potential target of 1, 4-pentadien-3-one derivatives

×

Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name
Last Name
Company Name
Country
State
Province
State
Region
State
Canton
Agree to Subscribe & Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
Thank you!
Error - something went wrong!